Table 3.

mRNA expression of SSTR subtypes in neuroendocrine carcinoma G3

Primary sites	Number	mRNA relative quantities (mean±SD)
		SSTR1	SSTR2	SSTR3	SSTR4	SSTR5
Colon	1	0.74	0.06	0	0	1.80
Stomach, Duodenum	2	0.41±0.19	1.02±0.86	1.71±2.41	0.02±0.02	0.29±0.13
Esophagus	2	0.005±0.007	0.04±0.04	0.002±0.003	0	0.02±0.02
Thymus	1	0.79	0.54	0	0	0.70
Mediastinum	1	0.06	0.18	0.02	0.01	0.28
Lung	5	0.31±0.30	* 1.01±2.98	0.00±0.01	0.46±1.06	0.00±0.23
Prostate	2	0.13±0.13	0.21±0.11	0	0.41±0.28	0.00±0.00
Breast	5	0.11±0.36	* 0.23±1.67	0.00±0.01	0.00±0.23	0.00±0.43
Uterine cervix	2	0.05±0.08	0.15±0.12	0	0.22±0.31	0.11±0.15

* p<0.05: Mann-Whitney’s U-test between SSTR2 and other subtypes.